Literature DB >> 2243057

Establishment of a macrophagelike cell line derived from U-937, human histiocytic lymphoma, grown serum-free.

Z L Kong1, M Miwa, H Murakami, K Shinohara.   

Abstract

A human macrophagelike cell line which grows in serum-free medium was established from a histiocytic lymphoma cell line, U-937. U-937 cells failed to differentiate into macrophagelike cells in serum-free medium plus 12-O-tetradecanoyl phorbol 13-acetate (TPA). Fibronectin and albumin in serum were necessary for differentiation of U-937 cells into macrophagelike cells in enriched RDF medium supplemented with insulin, transferrin, ethanolamine, selenite, egg yolk lipoprotein (eRDF-ITESL medium). The established cell line exhibited several characteristic properties of macrophage such as nitroblue tetrazolium reduction, phagocytic and alpha-naphthylbutyrate-esterase activities, and tumor necrosis factor and interleukin 1 production. At present the cells have been continuously maintained in eRDF-ITESL medium through over 150 passages.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2243057     DOI： 10.1007/bf02624468

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN： 0883-8364


  11 in total

1.  Egg yolk lipoprotein, a new supplement for the growth of mammalian cells in serum-free medium : Egg yolk lipoprotein for serum-free growth of cells.

Authors:  H Murakami; Y Okazaki; K Yamada; H Omura
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

Review 2.  Serum-free media used for cultivation of hybridomas.

Authors:  H Murakami
Journal:  Adv Biotechnol Processes       Date:  1989

3.  In vitro activation of a human macrophage-like cell line.

Authors:  H S Koren; S J Anderson; J W Larrick
Journal:  Nature       Date:  1979-05-24       Impact factor: 49.962

4.  Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.

Authors:  T Koizumi; Y Nakao; S Ishizuka; J Oshida; N Hara; N Ikekawa; T Fijita
Journal:  Arch Biochem Biophys       Date:  1990-02-01       Impact factor: 4.013

5.  Cell surface characteristics of human histiocytic lymhoma lines--I. Surface glycoprotein patterns.

Authors:  K Nilsson; L c Andersson; C G Gahmberg
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

6.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

7.  Vitamin D metabolites change the phenotype of monoblastic U937 cells.

Authors:  R C Dodd; M S Cohen; S L Newman; T K Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3':5'-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor.

Authors:  I L Olsson; T R Breitman; R C Gallo
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

9.  Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents.

Authors:  I L Olsson; T R Breitman
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

10.  Cholesterol requirement of P3-X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro.

Authors:  J D Sato; T Kawamoto; T Okamoto
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307
View more
  1 in total

1.  Stimulation of cell growth in the U-937 human myeloid cell line by honey royal jelly protein.

Authors:  K Watanabe; H Shinmoto; M Kobori; T Tsushida; K Shinohara; J Kanaeda; M Yonekura
Journal:  Cytotechnology       Date:  1998-01       Impact factor: 2.058
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.